JAC Advance Access published online on October 28, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl430
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Immunology, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA
* To whom correspondence should be addressed.
Correspondence
Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation
Govindarajan Rajagopalan 1 *, Robin Patel 2, Srini V. Kaveri 3, and Chella S. David 1
2 Divisions of Infectious Diseases and Clinical Microbiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
3 INSERM Unité 681 and Université Pierre et Marie Curie, Institut des Cordeliers, Paris, France
Govindarajan Rajagopalan, E-mail: rajagopalan.govindarajan{at}mayo.edu
This article has no Abstract.
Keywords:
superantigens; IVIg; HLA class II transgenic mice.
![]()
CiteULike
Connotea
Del.icio.us What's this?